Why AtaiBeckley Stock Soared Today
The psychedelic drugmaker is being acquired.
Overview
Shares of AtaiBeckley (NASDAQ: ATAI) surged on Thursday after the mental health-focused biotechnology company agreed to be acquired by pharmaceutical giant Eli Lilly (NYSE: LLY).
Image source: Getty Images.
Under the terms of the deal, Lilly will purchase AtaiBeckley for $6.75 per share in cash. The healthcare leader will also pay up to $2.50 per share in additional milestone payments if certain development and regulatory goals are achieved.
Details
Source
Originally published at www.fool.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.